Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
The specificity of these findings is demonstrated by a lack of comparable changes in schizophrenia; however, our findings do identify convergence between both disorders at the level of activity-mediated actin cytoskeletal regulation.
|
31220216 |
2020 |
Schizophrenia
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Given the crucial involvement of actin in these mechanisms, dysregulations of spine actin dynamics (reflected by alterations in dendritic spine morphology) can be found in a variety of neurological disorders ranging from schizophrenia to several forms of autism spectrum disorders such as fragile X syndrome (FXS).
|
29380377 |
2018 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
BEFREE |
Western blot analysis of fractions revealed decreased F-actin, increased G-actin, and decreased ratios of F-actin/total actin and F-actin/G-actin in schizophrenia.
|
29225346 |
2017 |
Schizophrenia
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Our studies indicate that a central cellular structure affected by schizophrenia susceptibility loci is the actin cytoskeleton, an organelle necessary for synaptic function in the presynaptic and postsynaptic compartment.
|
27927957 |
2016 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
BEFREE |
Consistent with this idea, altered expression of genes in the cell division cycle 42 (CDC42)-CDC42 effector protein (CDC42EP) signaling pathway, a key organizer of the actin cytoskeleton, was previously reported in DLPFC gray matter from subjects with schizophrenia.
|
25981171 |
2015 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
BEFREE |
Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder.
|
25113377 |
2015 |
Schizophrenia
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Disease-specific processes were identified in ID (actin cytoskeleton processes), schizophrenia (ubiquitin-related processes), and ASD (synaptic vesicle transport and exocytosis).
|
23582872 |
2013 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
PSYGENET |
We first carried out a preliminary array screen of pooled RNA, and then used RT-PCR to quantify five mRNAs which the array identified as differentially expressed in schizophrenia (myelin basic protein [MBP], myelin-oligodendrocyte glycoprotein [MOG], β-actin [ACTB], thymosin β-10 [TB10], and superior cervical ganglion-10 [SCG10]).
|
22675524 |
2012 |
Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
We first carried out a preliminary array screen of pooled RNA, and then used RT-PCR to quantify five mRNAs which the array identified as differentially expressed in schizophrenia (myelin basic protein [MBP], myelin-oligodendrocyte glycoprotein [MOG], β-actin [ACTB], thymosin β-10 [TB10], and superior cervical ganglion-10 [SCG10]).
|
22675524 |
2012 |
Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
The expression of CDC42 (cell division cycle 42), a RhoGTPase that regulates the outgrowth of the actin cytoskeleton and promotes spine formation, is also lower in schizophrenia; however, CDC42 mRNA is lower across layers 3-6, suggesting that other lamina-specific molecular alterations are critical for the spine deficits in the illness.
|
20385374 |
2010 |